This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
REPLENISH trial: TX-001HR (17β-estradiol and progesterone combination) significantly improved moderate to severe hot flushes in postmenopausal women. (June 2017)
Record Type:
Journal Article
Title:
REPLENISH trial: TX-001HR (17β-estradiol and progesterone combination) significantly improved moderate to severe hot flushes in postmenopausal women. (June 2017)
Main Title:
REPLENISH trial: TX-001HR (17β-estradiol and progesterone combination) significantly improved moderate to severe hot flushes in postmenopausal women